The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2020
Filed:
Aug. 29, 2017
Applicant:
Curna, Inc., Miami, FL (US);
Inventors:
Joseph Collard, Delray Beach, FL (US);
Olga Khorkova Sherman, Tequesta, FL (US);
Belinda De Leon, San Francisco, CA (US);
Carlos Coito, West Palm Beach, FL (US);
Jane H. Hsiao, Miami, FL (US);
Assignee:
CuRNA, Inc., Miami, FL (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 31/7088 (2006.01); C12Q 1/6813 (2018.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 31/7088 (2013.01); C12N 15/1138 (2013.01); C12Q 1/6813 (2013.01); C12N 2310/111 (2013.01); C12N 2310/113 (2013.01); C12N 2310/315 (2013.01);
Abstract
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Sodium channel, voltage-gated, alpha subunit (SCNA), in particular, by targeting natural antisense polynucleotides of Sodium channel, voltage-gated, alpha subunit (SCNA). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of SCNA.